Shamim Ruff

Shamim Ruff

Consejero General en NERVGEN PHARMA CORP. .
66 años
Health Technology
Commercial Services
Consumer Services

Perfil

Shamim Ruff is currently a Member at Regulatory Affairs Professionals Society, The Royal Society of Chemistry, American Society of Clinical Oncology, Inc., American Society of Gene & Cell Therapy, and Develop Innovate Advance.
Ms. Ruff is also the Chief Regulatory Affairs Officer at NervGen Pharma Corp.
starting in 2026.
Former roles include Executive Director-US & Global Regulatory Affairs at Amgen, Inc. from 2007 to 2011, Independent Director at Reata Pharmaceuticals, Inc. from 2021 to 2023, Chief Regulatory Affairs Officer & Senior VP at Sarepta Therapeutics, Inc. from 2015 to 2018, Vice President-Regulatory Affairs at Genzyme Corp.
from 2011 to 2012, and Chief Regulatory Officer at Stoke Therapeutics, Inc. Education includes undergraduate studies at the University of Leicester and graduate studies at Loughborough University.

Cargos activos de Shamim Ruff

EmpresasCargoInicio
NERVGEN PHARMA CORP. Consejero General 04/03/2026
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Develop Innovate Advance
Corporate Officer/Principal -
Corporate Officer/Principal -

Antiguos cargos conocidos de Shamim Ruff.

EmpresasCargoFin
REATA PHARMACEUTICALS, INC. Director/Miembro de la Junta 26/09/2023
SAREPTA THERAPEUTICS, INC. Consejero General 01/05/2018
Consejero General 01/12/2012
░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░ -
Ver el detalle de la experiencia de Shamim Ruff.

Formación de Shamim Ruff.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

74

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Health Services

Commercial Services

Develop Innovate Advance

Health Technology

Health Technology

ÚLTIMAS HORA | -40%. Las herramientas más útiles solo para suscriptores: ¡descubre las mejores inversiones del futuro!
d
:
:
APROVECHAR LA PROMOCIÓN